Shopping Cart 0
Cart Subtotal
AED 0

Sientra Inc (SIEN) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company's products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices such as vaginal stents, reconstructive products and specialty products. It offers services such as simplified account setup, monthly credit card style, billing system, easy orders and returns, one-of-a-kind capcon care program, and free shipping and returns. The company develops aesthetics medicine and plastic surgery implants for cosmetic and reconstructive markets. It markets its products across the US. Sientra is headquartered in Santa Barbara, California, the US.

Sientra Inc (SIEN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Sientra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Sientra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Sientra Inc, Medical Equipment, Deal Details 11

Asset Purchase 11

Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 11

Venture Financing 12

Miramar Labs Raises Additional USD2.3 Million in Venture Financing 12

Miramar Labs Raises USD2 Million in Venture Financing 13

Miramar Labs Raises USD1.2 Million in Financing Round 14

Miramar Labs Raises USD16 Million in Extended Series D Venture Financing 15

Miramar Labs Raises USD 10 Million In Series D Financing 16

Miramar Labs Raises USD 10 Million In Venture Financing 18

Miramar Labs USD 5 Million In Venture Financing 19

Sientra Raises USD 65 Million In Series C Financing 20

Private Equity 22

Miramar Labs Raises USD9 Million in Financing 22

Merger 24

Miramar Labs And Miramar Technologies Complete Reverse Merger Transaction 24

Equity Offering 25

Sientra Raises USD115 Million in Public Offering of Shares 25

Sientra to Raise up to USD50 Million in Public Offering of Shares 27

Sientra Raises USD66 Million in Public Offering of Shares 28

Sientra Raises USD75 Million in IPO 30

Asset Transactions 31

Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 31

Acquisition 32

Sientra Acquires Miramar Labs 32

Sientra Inc-Key Competitors 34

Sientra Inc-Key Employees 35

Sientra Inc-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Financial Announcements 37

Aug 07, 2018: Sientra reports second quarter 2018 financial results 37

May 09, 2018: Sientra Reports First Quarter 2018 Financial Results 39

Mar 13, 2018: Sientra Reports Fourth Quarter and Full Year 2017 Financial Results 40

Jan 08, 2018: Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue 42

Nov 07, 2017: Sientra Reports Third Quarter 2017 Financial Results 44

Aug 09, 2017: Sientra Reports Second Quarter 2017 Financial Results 45

May 09, 2017: Sientra Reports First Quarter 2017 Financial Results 46

Mar 14, 2017: Sientra Reports Fourth Quarter and Full Year 2016 Financial Results 47

Corporate Communications 49

Oct 06, 2017: Sientra Supports Reconstructive Breast Patients with Launch of Full Circle Grant Program and Revolutionary Portfolio of Tissue Expanders 49

Mar 01, 2017: Sientra Appoints Vidur Sahney as Vice President, Operations and Supply Chain 50

Feb 07, 2017: Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors 51

Product News 52

Apr 25, 2018: Sientra to Showcase OPUS Breast Products and miraDry fresh Procedure at American Society of Aesthetic Plastic Surgeons Meeting 52

Apr 18, 2018: Sientra Receives FDA Approval of PMA Supplement 53

Sep 28, 2017: Comprehensive Analysis of Long-Term Safety Studies Reaffirms Smooth and Textured Breast Implants as Safe & Important Option for Patients Undergoing Aesthetic or Reconstructive Breast Surgery 54

Other Significant Developments 55

Aug 15, 2018: Sientra FULL CIRCLE grant applications open to U.S. Breast Cancer Organizations 55

Sep 14, 2017: Industry Leaders Allergan and Sientra Invest in The American Society for Aesthetic Plastic Surgery for Breast Implant Research 56

Appendix 57

Methodology 57

About GlobalData 57

Contact Us 57

Disclaimer 57


List Of Figure

List of Figures

Sientra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Sientra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Sientra Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Sientra Inc, Medical Equipment, Key Facts, 2017 2

Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Sientra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Sientra Inc, Deals By Market, 2012 to YTD 2018 9

Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 11

Miramar Labs Raises Additional USD2.3 Million in Venture Financing 12

Miramar Labs Raises USD2 Million in Venture Financing 13

Miramar Labs Raises USD1.2 Million in Financing Round 14

Miramar Labs Raises USD16 Million in Extended Series D Venture Financing 15

Miramar Labs Raises USD 10 Million In Series D Financing 16

Miramar Labs Raises USD 10 Million In Venture Financing 18

Miramar Labs USD 5 Million In Venture Financing 19

Sientra Raises USD 65 Million In Series C Financing 20

Miramar Labs Raises USD9 Million in Financing 22

Miramar Labs And Miramar Technologies Complete Reverse Merger Transaction 24

Sientra Raises USD115 Million in Public Offering of Shares 25

Sientra to Raise up to USD50 Million in Public Offering of Shares 27

Sientra Raises USD66 Million in Public Offering of Shares 28

Sientra Raises USD75 Million in IPO 30

Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 31

Sientra Acquires Miramar Labs 32

Sientra Inc, Key Competitors 34

Sientra Inc, Key Employees 35

Sientra Inc, Subsidiaries 36

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sientra Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company's products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices such as vaginal stents, reconstructive products and specialty products. It offers services such as simplified account setup, monthly credit card style, billing system, easy orders and returns, one-of-a-kind capcon care program, and free shipping and returns. The company develops aesthetics medicine and plastic surgery implants for cosmetic and reconstructive markets. It markets its products across the US. Sientra is headquartered in Santa Barbara, California, the US.

Sientra Inc (SIEN)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Sientra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Sientra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Sientra Inc, Medical Equipment, Deal Details 11

Asset Purchase 11

Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 11

Venture Financing 12

Miramar Labs Raises Additional USD2.3 Million in Venture Financing 12

Miramar Labs Raises USD2 Million in Venture Financing 13

Miramar Labs Raises USD1.2 Million in Financing Round 14

Miramar Labs Raises USD16 Million in Extended Series D Venture Financing 15

Miramar Labs Raises USD 10 Million In Series D Financing 16

Miramar Labs Raises USD 10 Million In Venture Financing 18

Miramar Labs USD 5 Million In Venture Financing 19

Sientra Raises USD 65 Million In Series C Financing 20

Private Equity 22

Miramar Labs Raises USD9 Million in Financing 22

Merger 24

Miramar Labs And Miramar Technologies Complete Reverse Merger Transaction 24

Equity Offering 25

Sientra Raises USD115 Million in Public Offering of Shares 25

Sientra to Raise up to USD50 Million in Public Offering of Shares 27

Sientra Raises USD66 Million in Public Offering of Shares 28

Sientra Raises USD75 Million in IPO 30

Asset Transactions 31

Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 31

Acquisition 32

Sientra Acquires Miramar Labs 32

Sientra Inc-Key Competitors 34

Sientra Inc-Key Employees 35

Sientra Inc-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Financial Announcements 37

Aug 07, 2018: Sientra reports second quarter 2018 financial results 37

May 09, 2018: Sientra Reports First Quarter 2018 Financial Results 39

Mar 13, 2018: Sientra Reports Fourth Quarter and Full Year 2017 Financial Results 40

Jan 08, 2018: Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue 42

Nov 07, 2017: Sientra Reports Third Quarter 2017 Financial Results 44

Aug 09, 2017: Sientra Reports Second Quarter 2017 Financial Results 45

May 09, 2017: Sientra Reports First Quarter 2017 Financial Results 46

Mar 14, 2017: Sientra Reports Fourth Quarter and Full Year 2016 Financial Results 47

Corporate Communications 49

Oct 06, 2017: Sientra Supports Reconstructive Breast Patients with Launch of Full Circle Grant Program and Revolutionary Portfolio of Tissue Expanders 49

Mar 01, 2017: Sientra Appoints Vidur Sahney as Vice President, Operations and Supply Chain 50

Feb 07, 2017: Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors 51

Product News 52

Apr 25, 2018: Sientra to Showcase OPUS Breast Products and miraDry fresh Procedure at American Society of Aesthetic Plastic Surgeons Meeting 52

Apr 18, 2018: Sientra Receives FDA Approval of PMA Supplement 53

Sep 28, 2017: Comprehensive Analysis of Long-Term Safety Studies Reaffirms Smooth and Textured Breast Implants as Safe & Important Option for Patients Undergoing Aesthetic or Reconstructive Breast Surgery 54

Other Significant Developments 55

Aug 15, 2018: Sientra FULL CIRCLE grant applications open to U.S. Breast Cancer Organizations 55

Sep 14, 2017: Industry Leaders Allergan and Sientra Invest in The American Society for Aesthetic Plastic Surgery for Breast Implant Research 56

Appendix 57

Methodology 57

About GlobalData 57

Contact Us 57

Disclaimer 57


List Of Figure

List of Figures

Sientra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Sientra Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Sientra Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Sientra Inc, Medical Equipment, Key Facts, 2017 2

Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Sientra Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Sientra Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Sientra Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Sientra Inc, Deals By Market, 2012 to YTD 2018 9

Sientra Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 11

Miramar Labs Raises Additional USD2.3 Million in Venture Financing 12

Miramar Labs Raises USD2 Million in Venture Financing 13

Miramar Labs Raises USD1.2 Million in Financing Round 14

Miramar Labs Raises USD16 Million in Extended Series D Venture Financing 15

Miramar Labs Raises USD 10 Million In Series D Financing 16

Miramar Labs Raises USD 10 Million In Venture Financing 18

Miramar Labs USD 5 Million In Venture Financing 19

Sientra Raises USD 65 Million In Series C Financing 20

Miramar Labs Raises USD9 Million in Financing 22

Miramar Labs And Miramar Technologies Complete Reverse Merger Transaction 24

Sientra Raises USD115 Million in Public Offering of Shares 25

Sientra to Raise up to USD50 Million in Public Offering of Shares 27

Sientra Raises USD66 Million in Public Offering of Shares 28

Sientra Raises USD75 Million in IPO 30

Sientra Acquires Tissue Expander Portfolio from Specialty Surgical Products 31

Sientra Acquires Miramar Labs 32

Sientra Inc, Key Competitors 34

Sientra Inc, Key Employees 35

Sientra Inc, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Sientra Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.